Reason for request
Inclusion
Clinical Benefit
| Moderate |
Moderate AB pending re-assessment of oral antihistamines. |
Clinical Added Value
| no clinical added value |
No improvement in actual benefit (IAB V) compared with other oral H1 antihistamines available in oral form. |
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
yFEnTEwgdjd6Zzcd
Listen
